Virtual HDU Phase 3: wireless vital sign monitoring system testing on a surgical ward
| ISRCTN | ISRCTN10708234 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN10708234 |
| ClinicalTrials.gov (NCT) | Nil known |
| Clinical Trials Information System (CTIS) | Nil known |
| Protocol serial number | Sponsor (CTRG) and Research and Development ref: 13976 |
| Sponsor | University of Oxford |
| Funder | NIHR Oxford Biomedical Research Centre |
- Submission date
- 10/05/2019
- Registration date
- 14/06/2019
- Last edited
- 31/03/2020
- Recruitment status
- Suspended
- Overall study status
- Completed
- Condition category
- Other
Plain English summary of protocol
Background and study aims
Hospital patients have their vital signs measured regularly. If they are very ill they may need to have them measured continuously. Current monitors are bulky or awkward. This can prevent them from moving and walking enough to help them get better. The Virtual HDU study is aiming to prevent patients from needing this type of monitoring unnecessarily. There are now small wireless vital sign monitors available. In the future we want to put these on hospital patients who are ill but, not ill enough to need standard wired monitors. The monitors may pick up when a patients vitals worsen. It will alert the nurses or doctors to check them and they may give them the treatment they need earlier. This could improve their recovery and could reduce the length of their hospital stay.
Who can participate?
Healthy clinical staff volunteers.
What does the study involve?
This study, Phase 3, involves testing different monitors on a NHS hospital ward to see how they work. This includes checking if the wireless signal is affected by the wards layout. We will test if the monitors are comfortable to wear and easy to use. this will then enable the refinement of the technology before patient testing. They will each wear a monitor for the duration of their shift, when appropriate. They will then complete a questionnaire about wearing the monitor.
What are the possible benefits and risks of participating?
No benefits or risks to participating.
Where is the study run from?
The study will be run by the Critical Care Research Group at the Kadoorie Centre for Critical Care Research and Education.
When is the study starting and how long is it expected to run for?
The study started in April 2019 and will run until October 2021 (updated 20/11/2019, previously: August 2019)
Who is funding the study?
This study is funded by the NIHR Oxford Biomedical Research Centre.
Who is the main contact?
Louise Young
louise.young@ndcn.ox.ac.uk
Contact information
Public
Kadoorie Centre for Critical Care Research and Education
Level 3
John Radcliffe Hospitals
Headley Way
Oxford
OX3 9DU
United Kingdom
 ORCID ID |
0000-0001-9094-1733 |
|---|---|
| Phone | 01865 231482 |
| louise.young@ndcn.ox.ac.uk |
Study information
| Primary study design | Observational |
|---|---|
| Study design | Observational single-site mixed methods study |
| Secondary study design | Mixed methods study |
| Study type | Participant information sheet |
| Scientific title | Virtual HDU Phase 3: locational testing of ambulatory monitoring systems on a surgical ward |
| Study acronym | Virtual HDU Phase 3 |
| Study objectives | True continuous vital sign monitoring within the ward environment is not currently feasible due to limitations in vital sign monitoring technology but, is commonly believed to increase the timely detection of patient deterioration. Wearable monitors may provide an alternative continuous monitoring system, affording patients more mobility, less discomfort, reduce nursing time and improve the early detection of abnormal physiological parameters. Barriers to the successful implementation of these wearable devices are reliability, efficiency and data processing systems. This study aims to demonstrate and test robust a wearable monitoring system with good reliability and reliability, but also be acceptable to end-users of the system. |
| Ethics approval(s) | Approved 22/02/2019, Medical Sciences Interdivisional Research Ethics Committee, University of Oxford (Research Services, University of Oxford, Wellington Square, Oxford, OX1 2JD; +44(0)1865 616577; +44(0)1865 280467; ethics@medsci.ox.ac.uk), ref: R61573/RE001. |
| Health condition(s) or problem(s) studied | Healthy volunteers |
| Intervention | This study has been designed to optimise ambulatory monitoring systems to provide reliable continuous data recording in a clinical setting. This will be done during several rounds of testing and troubleshooting, to optimise the systems being tested for clinical use. Healthy staff volunteers will wear the ambulatory monitor(s) around the target ward for up to the length of a working shift (up to 12 hours). They will wear up to three different combinations of ambulatory monitor. The participants can remove the monitor when needed to undertake direct patient care. Information regarding the proprtion of time each vital sign parameter is recored versus the time the device was worn. The availability of data collected (via bluetooth and Wi-Fi) will be analysed. The data collection system (software and hardware) will be tested and analysed to detect and troubleshoot and fix errors and improve reliability. Participants will be asked to complete a questionnaire, rating the user experience of the ambulatory monitors. Study is complete once all participants have worn all of the monitors and completed all questionnaires. There will be no further follow-up. |
| Intervention type | Device |
| Phase | Not Applicable |
| Drug / device / biological / vaccine name(s) | N/A |
| Primary outcome measure(s) |
The proportion of time each vital sign parameter (heart rate, SPO2 and breathing rate) is recorded versus time the device is worn. |
| Key secondary outcome measure(s) |
1. The frequency and duration of data drop-out for each vital sign parameter. |
| Completion date | 05/10/2021 |
Eligibility
| Participant type(s) | Healthy volunteer |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | All |
| Target sample size at registration | 20 |
| Key inclusion criteria | 1. Staff working for the Oxford University Hospitals NHS Foundation Trust, in the designated area. 2. Willing and able to give informed consent for the study. 3. Aged 18 or over 4. In good health. |
| Key exclusion criteria | 1. Allergies to adhesives dressings or metals e.g. Nickel. 2. Intra-cardiac device e.g. permanent pacemaker (only applicable to the chest patch monitor). |
| Date of first enrolment | 17/06/2019 |
| Date of final enrolment | 05/10/2020 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
Headington
Oxford
OX3 9DU
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Data sharing statement to be made available at a later date |
| IPD sharing plan | The data sharing plans for the current study are unknown and will be made available at a later date. |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
31/03/2020: Due to current public health guidance, recruitment for this study has been paused.
20/11/2019: The following changes were made to the trial record:
1. The recruitment end date was changed from 05/10/2019 to 05/10/2020.
2. The overall end date was changed from 05/10/2020 to 05/10/2021.
3. The intention to publish date was changed from 01/05/2020 to 05/10/2022.
4. The plain English summary was updated to reflect these changes.
17/09/2019: The overall trial end date was updated from 22/08/2019 to 05/10/2020.
10/09/2019: The recruitment end date was changed from 22/08/2019 to 05/10/2019.
14/06/2019: The recruitment start date was changed from 30/04/2019 to 17/06/2019.
14/05/2019: Trial's existence confirmed by the Medical Sciences Interdivisional Research Ethics Committee.
